Por: Fox Business Business September 01, 2023
NetChoice Vice President and general counsel Carl Szabo discusses the Biden administration's latest move to gain more control over American businesses on 'The Big Money Show.' The (FTC) will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to extend the market dominance of two Horizon drugs. The FTC filed a lawsuit on May 16 to stop the deal... + full article
Los Angeles Times USA Science September 01, 2023
Amgen can move forward with its $27.8-billion takeover of Horizon Therapeutics after the U.S. Federal Trade Commission said Friday that it had accepted a binding settlement that the combined company won’t bundle together two of Horizon’s blockbuster drugs. The acquisition... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press
US sues to block Amgen’s $27.8 billion takeover of Horizon Therapeutics | The Boston Globe
The Boston Globe USA Tech May 17, 2023
The Federal Trade Commission on Tuesday sued to block drugmaker Amgen’s $27.8 billion acquisition of pharmaceutical company Horizon Therapeutics, saying it would thwart competition in the drug industry.The FTC said the deal would allow Amgen to exploit a maneuver known as... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS
ABC News USA Business May 16, 2023
The U.S. is attempting to block the proposed acquisition of Horizon Therapeutics for more than $26 billion by biotech drug developer Amgen on antitrust grounds. The Federal Trade Commission said Tuesday that the deal, announced in December, would give Amgen unfair leverage to... + más
Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon | ABC News
Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon | Associated Press
Los Angeles Times USA Business May 16, 2023
The Federal Trade Commission sued Tuesday to block Amgen's $27.8-billion deal to buy Horizon Therapeutics, arguing the tie-up would stifle competition for the development of treatments for serious illnesses. In a sealed complaint filed in Illinois federal court, the FTC... + más
ABC News USA Health May 16, 2023
Associated Press USA Health May 16, 2023
Associated Press USA Business December 12, 2022
Amgen is spending more than $26 billion to dive deeper into rare disease treatments with a deal for drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a thyroid eye disease treatment that... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | ABC News
About iurex | Privacy Policy | Disclaimer |